NATIONAL TOXICOLOGY PROGRAM Technical Report Series No. 438 TOXICOLOGY AND CARCINOGENESIS STUDIES OF BENZETHONIUM CHLORIDE (CAS NO. 121-54-0) IN F344/N RATS AND B6C3Fl MICE (DERMAL STUDIES) U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health FOREWORD The National Toxicology Program (NTP) is made up of four charter agencies of the U.S. Department of Health and Human Services (DHHS): the National Cancer Institute (NCI), National Institutes of Health; the National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health; the National Center for Toxicological Research (NCTR), Food and Drug Administration; and the National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control. In July 1981, the Carcinogenesis Bioassay Testing Program, NCI, was transferred to the NIEHS. The NTP coordinates the relevant programs, staff, and resources from these Public Health Service agencies relating to basic and applied research and to biological assay development and validation. The NTP develops, evaluates, and disseminates scientific information about potentially toxic and hazardous chemicals. This knowledge is used for protecting the health of the American people and for the primary prevention of disease. The studies described in this Technical Report were performed under the direction of the NIEHS and were conducted in compliance with NTP laboratory health and safety requirements and must meet or exceed all applicable federal, state, and local health and safety regulations. Animal care and use were in accordance with the Public Health Service Policy on Humane Care and Use of Animals. The prechronic and chronic studies were conducted in compliance with Food and Drug Administration (FDA) Good Laboratory Practice Regulations, and all aspects of the chronic studies were subjected to retrospective quality assurance audits before being presented for public review. These studies are designed and conducted to characterize and evaluate the toxicologic potential, including carcinogenic activity, of selected chemicals in laboratory animals (usually two species, rats and mice). Chemicals selected for NTP toxicology and carcinogenesis studies are chosen primarily on the bases of human exposure, level of production, and chemical structure. Selectionper se is not an indicator of a chemical’s carcinogenic potential. These NTP Technical Reports are available for sale from the National Technical Information Service, U.S. Department of Commerce, 5285 Port Royal Road, Springfield, VA 22161 (703-487-4650). Single copies of this Technical Report are available without charge while supplies last from NTP Central Data Management, NIEHS, P.O. Box 12233, MD AO-01, Research Triangle Park, NC 27709 (919-541-3419). NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF BENZETHONIUM CHLORIDE (CAS NO. 121-54-0) IN F344/N RATS AND B6C3Fl MICE (DERMAL STUDIES) NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 July 1995 NTP TR 438 NIH Publication No. 95-3169 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health ~~~~ ~~ 2 Benzethonium Chloride, NTP TR 438 National Toxicology Program NTP Pathology Working Group Evaluated and interpretedr& and reportedjir&hgs Evaluated slid&, prepared pathology reporton rats (7 January 1992) C.J. Alden, Ph.D. G.A. Boorman, D.V.M., Ph.D. L.H. Brennecke, D.V.M., Chair D.A. Bridge, B.S. Pathology Associates,Inc. W.W. Carlton, MS., D.V.M., Ph.D. J.R. Bucher, Ph.D. Purdue University M.R. Elwell, D.V.M., Ph.D. R. Cattley, M.S., V.M.D., Ph.D. T.J. Goehl, Ph.D. Chemical Industry Institute of Toxicology J.K. Haseman, Ph.D. J.R. Hailey, D.V.M. D.S. Marsman, D.V.M., Ph.D. National Toxicology Program G.N. Rao, D.V.M., Ph.D. C.C. Shackelford, D.V.M., MS., Ph.D. G.S. Travlos, D.V.M. National Toxicology Program D.B. Walters, Ph.D. R.C. Sills, D.V.M., Ph.D. K.L. Witt, M.S., Oak Ridge Associated Universities National Toxicology Program K. Yoshitomi, D.V.M., Ph.D. Experimental PathologyLaboratories, Inc. Battelle Columbus Laboratories Evaluated sliaiq prepared pathology reporton mice Conducted studies, evaluated pathologyfindings (23 Januq 1992) P.J. Kurtz, Ph.D., Principal Investigator M.P. Jokinen, D.V.M., Chair M.R. Hejtmancik, Ph.D. National Toxicology Program R.L. Persing, D.V.M. W.W. Carlton, MS., D.V.M., Ph.D. Purdue University M.R. Elwell, D.V.M., Ph.D. National Toxicology Program Experimental Pathology Laboratories, Inc. J.R. Hailey, D.V.M. Provided pathology quality assurance National Toxicology Program A. Kharazi, M.D., Ph.D. J.F. Hardisty, D.V.M., Principal Investigator Veteran Administration Medical Center K. Yoshitomi, D.V.M., Ph.D. C.C. Shackelford, D.V.M., M.S., PbD. National Toxicology Program D.L. Wolf, D.V.M., Ph.D. Dynamac Corporation Chemical Industry Institute of Toxicology Prepared quality assurance audits K. Yoshitomi, D.V.M., Ph.D. Ekperimental Pathology Laboratories, Inc. S. Brecher, Ph.D., Principal Investigator Biotechnical Services, Inc. Analytical Sciences, Inc. Prepared Technical Report Provided stahtical analyses D.D. Lambright, Ph.D., Principal Investigator R.W. Morris, M.S., Principal Investigator J.R. Beverly, B.A. N.M. Garrison, B.S. S.R. Gunnels, M.A. S.R. Kennedy, M.S. T.A. King-Hunter, B.S. T.L. Rhoades, B.S. K.L. Shaw, B.A. 3 CONTENTS ABSTRACT ................................................................... 5 EXPLANATION OF LEVELS OF EVIDENCE OF CARCINOGENIC ACTMTY ............... 9 TECHNICAL REPORTS REVIEW SUBCOMMITTEE ................................... 10 SUMMARY OF TECHNICAL REPORTSREVIEW SUBCOMMITTEE COMMENTS ........... 11 INTRODUCTION .............................................................. 13 MATERIALSANDMETHODS .................................................... 17 RESULTS .................................................................... 25 DISCUSSION AND CONCLUSIONS ................................................ 47 REFERENCES ................................................................ 49 APPENDIX A Summary of Lesions in Male Rats in the 2-Year DermalStudy of Benzethonium Chloride ........................................... 53 APPENDIX B Summary of Lesions in Female Ratsin the 2-Year DermalStudy of Benzethonium Chloride ........................................... 87 APPENDIX C Summary of Lesions in Male Micein the 2-Year DermalStudy of Benzethonium Chloride ........................................... 113 APPENDIX D Summary of Lesions in Female Mice in the 2-Year DermalStudy of Benzethonium Chloride ........................................... 143 APPENDIX E GeneticToxicology ................................................. 175 APPENDIX F OrganWeights and Organ-Weight-to-BodyweightRatios .................... 183 APPENDIX G ChemicalCharacterization and Dose FormulationStudies ................... 191 APPENDIX H Ingredients. Nutrient Composition.andContaminantLevels in NIH-07 Rat and Mouse Ration ..................................... 207 APPENDIX I SentinelAnimalProgram ............................................ 213 4 Benzethonium Chloride, NTP TR 438 0 ABSTRACT BENZETHONIUM CHLORIDE CAS NO.121-54-0 Chemical Formula: ~,H,,NO,-Cl Molecular Weight: 448.1 Synonyms: Benzyldimethyl-p-(l,1,3,3-tetramethylbutyl) phenoxyethoxyethylammonium chloride; diisobutylphenoxyethoxy- ethyldimethyl benzyl ammonium chloride;p-tert-octylphenoxyethoxyethyldimethylbenzylammonium chloride Trade names: Anti-gem 77, Antiseptol, BZT, Diapp, Disilyn, Hyamine, Hyamine 1622, Phemeride, Phemithyn, Polymine D, Quatrachlor, Solamine Benzethonium chloride is used primarilyin cosmetics necropsy included thickening or hardening of the skin for its antimicrobial and cationic surfactant proper- atthesite of application in all rats administered ties. Benzethonium chloride was nominated by the 50 or 100 mgkg and in 25 mgkg males. Lesions at National Cancer Institute to the NTP for study from the site of application appeared crusty or red-grey in a class study of chemicals used as biocides. The color. Epithelial hyperplasia with or without inflam- chemical was selected based on a suspicion of car- mation occurred atthesite of application in all cinogenicity and its known widespread human expo- groups of males and females administered benze- sure. Male and female F344/N rats and B6C3Fl mice thonium chloride. were topically administered benzethonium chloride (greater than 98% pure) for 16 days, 13 weeks, or 2 years. Genetic toxicology studies were conducted in 16-DAY STUDY IN MICE Salmonellatyphimurium and cultured Chinese ham- Groups of five male and five female B6C3Fl mice ster ovaty cells. were topically administered 0, 6.3, 12.5, 25, 50, or 100 mg benzethonium chloridekg body weight. Mice were administered a total of 12 doses ina fixed 16-DAY STUDY IN RATS volume of 100 pL ethanol. One 100 mglkg male Groups of five male and five female F344/Nrats were mouse died on day 4 of the study. Final mean body topically administered 0,6.3, 12.5, 25, 50, or 100 mg weights of all groups of males and females were benzethonium chloridekg bodyweight. Rats were similar to those of the controls. Clinical findings administered a total of 12 doses in a fixed volume of included mild irritation at the site of application in 250 pL ethanol. All rats survived to the end of the 50 and 100 mgkg males and females and in 25 mglkg study. The final mean body weights and body weight males. Epithelial hyperplasia withor without inflam- gains of rats administered 50 or 100 mg benze- mation